Table 1 Demographic features of the study population.

From: Evaluating a novel approach to placenta accreta spectrum management: the modified Triple-P technique with cystoinflation (a randomized controlled trial)

Demographic features

Cystoinflation group (n = 75)

Control group (n = 75)

P-value

Age (years)

32.65 ± 3.164

31.99 ± 2.807

0.207

BMI (kg/m2)

30.72 ± 1.936

30.65 ± 1.754

0.814

Gestational age (weeks)

36

16 (21.3%)

15 (20%)

0.931

37

50 (66.7%)

51 (68%)

38

8 (10.7%)

7 (9.3%)

39

1 (1.3%)

2 (2.7%)

Parity

1

2(2.7%)

3 (4%)

0.978

2

19 (25.7%)

21 (28%)

3

37 (49.3%)

36 (48%)

4

16 (21.3%)

14 (18.7%)

5

1 (1.3%)

1 (1.3%)

Socioeconomic status

Low

10 (13.2%)

11 (14.7%)

0.636

Medium

54 (72%)

49 (65.3%)

High

11 (14.7%)

15 (20%)

Number of previous C-section

1

2 (2.7%)

3 (4%)

0.940

2

36 (48%)

38 (50.7%)

3

32 (42.7%)

29 (38.7%)

4

5 (6.7%)

5 (6.7%)

Type of placenta previa

Type3

28

32

0.309

Type 4

47

43

Type of PAS

Accreta

2

2

0.802

Increta

38

42

Percreta

35

31

Preoperative Hb (g/dL)

12.47 ± 1.018

12.52 ± 1.095

0.776

Preoperative residual urine Volume

15 (10–30)

15 (10–30)

0.863

  1. Values are mean ± SD, and number (proportions). P value < 0.05.